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 2 
The Effectiveness of Treatment for Substance Dependence within the 





This review was jointly commissioned by Geoff Cooke, Area Drug Strategy Co-ordinator 
for the Prison Service, the East and West Kent Health Authorities and the West Sussex 
Drug Action Team, as part of a wider programme of work evaluating the outcome 
effectiveness of drug treatment services within Kent, East Surrey and Sussex priso s. The 
specific aims of this scoping review were to identify treatments that are used for those 
with substance dependence, describe the current regimes available in prison, and to 
evaluate the effectiveness of the treatments, drawing on research evidence from the UK 
and the US through major bibliographic databases, such as BIDS, and other published 
and publicly available research materials.  
 
Illicit drugs and penal policy 
Drug use among offenders causes significant problems for the Prison Service, including 
illicit trading and bullying, as well as presenting public-health r sks, for prisoners, staff 
and local communities. The Government and the Prison Service have developed 
strategies to address the issue of drug use among offenders in response to intense litical 
pressure. In 1998, the White Paper Tackling Drugs to build a Better Britain (Lord 
President of the Council, 1998) and the Prison Service Tackling Drugs in Prison set the 
objectives of increasing participation of problem drug users in drug teatment 
programmes, sustaining the use of Mandatory Drug Testing and improving security, 
collaborating with community agencies to ensure continuity of care was linked to 
community provision. The Updated Drug Strategy stressed the continued importance of 
reducing the prevalence of drugs and drug-related crime, but also emphasised the need to 
reduce the demand for drugs, through extra investment in the number of treatment places 
available in high and low intensity programmes for problematic drug users and enhanced 
throughcare (Drugs Strategy Directorate, 2002). 
 
The treatment of drug and alcohol dependence 
The treatments for drug and alcohol dependence vary greatly, reflecting the absence of 
consensus over the nature of the problem. The majority of randomised controlled trials 
focus on alcohol related disorders; those with drug therapies have focused on methadone 
or comparisons with other substitute drugs. There has been no unequivocal evidence, 
however, favouring one treatment over another. The review considers arguments as to 
why specialised treatments have often been regarded as limited in their role in reducing 
drug and alcohol use, the significance of spontaneous remission, and the fact that the 
socio-economic and psychiatric profile of an individual can be a better predictor of 
treatment success than type or intensity of treatment.  The review acknowledges that 
abstinence should not be the sole criterion for success of a treatment intervention: formal 
treatment may not have a major role in abstinence, but harm red ction and reduction in 
use leads to positive economic returns to society and the criminal justice system, reduces 
criminal activity and hospital admissions and improves health status.
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Drug services in prison 
Prison provides an opportunity for thetreatment and rehabilitation of offenders with drug 
and alcohol related problems. A number of drug treatments operate in the British prison 
system, ranging from 12 Steps facilitation to acupuncture, cognitive-behavioural 
methods, educational programmes, relapse prevention training, therapeutic communities 
and pharmacological treatments. There has been a lack of systematic evaluations of these 
interventions within the prison system.  
 
The evidence base for prison treatment 
Some of the findings include: 
 
§ Few independent studies of 12 Steps facilitation methods, and the evaluation 
studies to date have been methodologically poor.  
§ Cognitive-behavioural therapies (CBT) have a consistent record for effectiveness, 
having value in motivating people to change behaviour and helping with co-
occurring problems such as anxiety and depression. 
§ Evidence for the effectiveness of Motivational Interviewing is strong, especially 
with those resistant to change. 
§ Evidence for non-directive counselling techniques was not strong in general, and 
even more limited for its use within the criminal justice system.  
§ Although popular, evidence is lacking for the effectiveness of educational 
programmes. The model of change advocated by Prochaska and DiClemente 
(1986), however, suggests they may help those who are pre-cont mplative to 
move to a contemplative state, increasing the likelihood of eventual behaviour 
change.  
§ Educational programmes may have some benefit for imparting specific 
information to improve health and reduce risk-taking behaviour, for example, 
preventing the transmission of communicable diseases. 
§ The most commonly used pharmacotherapy in prison is methadone maintenance. 
Despite the difficulties posed for prisons, there is good evidence that methadone 
maintenance reduces inject g risk behaviour in prison, reduces the risk of 
overdose on release and has a positive impact on crime rates.  
§ Relapse prevention is generally effective, especially with alcohol related 
problems. 
§ Therapeutic Communities (TC) in American prisons have claimed consistent 
reductions in reconviction rates and relapse into drug use. The existing US 
research is methodologically flawed, however; and even if success rates were 
higher than claimed, TCs could be the least cost- ffective option for treating drug 
and alcohol dependence. The forthcoming expansion of TCs within the English 
prison system will provide an opportunity for rigorous evaluation research. 
 
Current treatment regimes 
Although there is some US-based research, there have been no methodologically rigorous 
evaluations of drug services within British prisons. Running treatment programmes and 
conducting research within the prison environment face a number of problems intrinsic to 
 4 
the system. These range from disagreement about treatment goals to obtainin  client data, 
issues of confidentiality, the availability of drugs, and divergence in meeting targets over, 
for example, mandatory drugs testing.  
 
Conclusion  
Although formal treatment appears to have a relatively minor role in helping people with 
drug problems, this Prison Service strategy is rational, in economic terms, because the 
benefits from reductions in offending behaviour and improvements in health status will 
outweigh the costs of treatment to the Prison Service.  Intervention has the potential of 
improving prison security, as well as the health and social functioning of prisoners, and it 
can enhance the achievement of key Prison Service aims and objectives, such as the 
rehabilitation of offenders. The evidence is strongest for interventions based on 
cognitive-behavioural principles, particularly if this is understood to include Motivational 
Interviewing. The greatest threat to the success of prison-based treatment comes from the 
failure of throughcare and aftercare arrangements, which are partly beyond the control of 
the prison authorities. There is an urgent need for independent and systematic outcome 
evaluations of drug services in prison, in line with the commitment of the Prison Service 














2. Introduction  
This review will identify current regimes within the prison system for the treatment of 
people with drug and alcohol problems and will review the evidence on their 
effectiveness. The main source of data is the current literatre on he effectiveness of 
treatment for substance dependence and on treatment regimes for prisoners. The review is 
a scoping review rather than a comprehensive, systematic review; that is to say, the 
literature search was restricted to major bibliographic databases like BIDS, PsychInfo and 
Project Cork, and to published and publicly available research.   
 
First, the review outlines briefly the problems illicit drug use poses for the Prison Service. 
The Government and Prison Service policy of reducing drug use in prison, while 
providing effective help for offenders who have drug problems, is then summarised. An 
overview of the literature on treatment is presented, before the literature on treatment in 




3. ILLICIT DRUGS AND PENAL POLICY  
Under the Misuse of Drugs Act 1977, the use of all drugs proscribed by law is classified 
as misuse. Drug misuse may be recreational and involve few current problems for the 
individual; it may involve physical and/or psychological dependence, and be termed drug 
dependence; or it may be part of a wider spectrum of problematic or harmful behaviour, 
and be termed drug abuse. The American Psychiatric Association (1994) definition of 
substance abuse is use that leads to clinically significant impairment or distress, including 
failure to fulfil major role obligations, recurrent use in physically hazardous situations, 
recurrent substance related legal problems and persistent or recurrent interpersonal 
problems related to substance use  
 
Although the relationship between drug use and crime is a complex one, which cannot be 
reduced to a simple need to commit property crimes or prostitution in order to pay for 
illicit drugs (Hammersley et al., 1989), there is political pressure to reduce drug use 
amongst offenders.  In the 1995 White Paper Tackling Drugs Together, the Conservative 
Government responded to public concern about drug related crime by adopting the 
objectives of reducing the incidence of such crimes, reducing public fear of such crimes 
and reducing the level of drug misuse in prison (Lord President of the Council, 1995: 
para 1.5).  
 
In formulating the latter objective, the Government was aware that illicit drug use causes 
a number of problems for the Prison Service; both for discipline, the illicit trade in drugs 
having been linked to bullying and on occasion prison disorders, and for the prevention 
of suicide, about 75% of all self-inflicted deaths in custody being drug related (HM Chief 
Inspector of Prisons, 1999: appendix 1.8). Moreover, drug offences have made a 
significant contribution to the growth in the prison population, which has increased 
pressure on the prison system over the last 20 years. Illicit drug use in prison also has 
public health implications, as seen in the outbreak of the blood-borne diseases hepatitis B 
and HIV/AIDS in HM Prison Glasgow in 1993 (Hutchinson et al., 1998). The Glasgow 
outbreak showed that longstanding concerns about the transmission of HIV and other 
diseases through the sharing of injecting equipment in prison were not without 
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foundation, and that prison drug use led to heightened risks for prisoners, prison staff and 
local communities. 
 
The 1995 White Paper Tackling Drugs Together announced that reducing drug misuse 
would become a key performance indicator for the Prison Service, and that improved 
security, mandatory drug testing for prisoners and effective treatment services were the 
means by which improvements would be achieved (Lord President of the Council, 1995: 
para 1.6). The incoming Labour Government endorsed this trategy in its 1998 White 
Paper Tackling Drugs to Build a Better Britain (Lord President of the Council, 1998). It 
noted that there was an acute shortage of drug services nationwide, and set the objective 
of increasing the participation of problem drug users, including prisoners, in drug 
treatment programmes (Lord President of the Council, 1998: aim 3). The emphasis was 
placed on encouraging the Prison Service to collaborate with community based agencies 
in order to introduce effective drugs services into prisons: the Prison Service, the 
Government announced, “should aim to direct resources from within (its) budget to 
drugs-specific partnership work, including treatment provision, with explicit priority 
given to this work in the Prison Service business plan, and performance indicators and 
targets aligned explicitly to the new strategy” (Lord President of the Council, 1998: aim 
3). The Government also stressed the need for throughcare and aftercare arrangements for 
drug misusing prisoners to be “coherent, focused and linked to community provision” 
(ibid.). 
 
The Prison Service published its drugs strategy, Tackling Drugs in Prison in 1998, to 
coincide with the Government White Paper (Prison Service, 1998). In this and subsequent 
strategy documents, the Service aims to be able to offer support and treatment to any 
prisoner with a drug problem. In order to do this, it will improve the availability and 
quality of treatment programmes in prison, and increase the availability of places on drug 
free wings. It is also committed to continuing the Mandatory Drug Testing programme, 




The updated strategy was released in November 2002. The importance of reducing the 
prevalence of drugs, and reducing drug related crime remains, but there is an increas d 
emphasis on reducing the demand for drugs, by increasing the number of treatment places 
for problematic drug users. Annual expenditure will increase, allowing for an expansion 
of the provision of substance misuse treatment within the youth justice system, and an 
increase in prison-based treatment provision with additional places in high and low 
intensity treatment programmes and enhanced throughcare (Drugs Strategy Directorate, 
2002). 
 
A key component in the Prison Service strategy is CARAT (Counselling, Assessment, 
Referral, Advice, and Throughcare), an initiative aimed at providing specialized 
treatment and throughcare for drug users in prison. Prison throughcare and aftercare have 
longstanding problems, the House of Commons Social Services Committe  having 
criticised the lack of liaison between prisons and community-based agencies in its 1986 
report on the Prison Medical Service (Social Services Committee, 1986). The Home 
Office (1988) responded to the Social Services Committee with a policy statement 
committing the Prison Service to better liaison. In 1998, however, the Parliamentary All-
Party Drugs Misuse Group (1998) was extremely critical of the quality of aftercare for 
offenders with drug problems, observing that to release drug offenders who had received 
treatment in prison, without providing aftercare, including help with accommodation and 
employment, was not cost-effective. In response, the Government agreed to contribute 
£72.5 million over three years to CARAT. 
 
The CARAT initiative was launched in 1999 (Gravett, 2000). It funds a range of 
interventions, starting with an initial needs assessment on a prisoner’s reception into a 
prison or Young Offender Institution (YOI), and it helps promote liaison between prison 
service establishments and community agencies, in order to ensure continuity of care. In 
Hull, for example, the Breaking the Chain project provides a social worker to visit 
prisoners three months prior to release, to assess their treatment needs. A treatment plan 
is agreed between HM Prison Hull and the project workers, and regular contact is 
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maintained with t e prisoner for up to six weeks after release. CARAT also enables 
prison staff to continue providing services to ex-prisoners for a short period after release. 
 
Reports from HM Chief Inspector of Prisons in 1999 showed that, one year after the 
introduction of the Prison Service drugs strategy, it was not being implemented 
consistently across regions and kinds of establishment (Gravett, 2000). While many adult 
prisons were making progress, the YOIs, where the highest proportion of offenders with 
drug problems are found, appeared to have fallen behind schedule. Of five YOIs 
inspected, for example, only one was making acceptable progress in the view of the Chief
Inspector of Prisons, and four were not (Gravett, 2000: 184). Despite this poor start, by 
the year 2001, only 12% of prisoners were testing positive for drugs, on average, 
compared with over 30% when testing was introduced, and more than 55,000 prisoners 
each year were agreeing to voluntary drug testing in England and Wales (Priso  Service 
Agency, 2001). 
 
Unfortunately, it has been more difficult to influence throughcare and aftercare, which 
involves the cooperation of other agencies. The provision of funding for transitional 
aftercare under the CARAT initiative appears to have encouraged other authorities to do 
less (Burrows et al., 2000). Part of the problem is that responsibility for aftercare for ex-
prisoners falls between different agencies: 
 
… responsibility for this issue does not fall to any single agency or post-
holder. Indeed, it is not the top priority for any of the six or more agencies 
who have been identified as critical to the delivery of an effective service.  
(Burrows et al., 2000: 40) 
 
Given the competition for scarce resources, it would not be surprising if agencies funded 
by the Home Office and the Department of Health attempted to offload expenditure onto 
each other, and this seems to have happened to some extent.  Several local authorities 
have disqualified ex-prisoners from receiving drug services, for example, thereby 
increasing the risk of unsuccessful rehabilitation (Burrows et al., 2000).   
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Summary The Prison Service is committed to introducing effective services for those 
prisoners who have problems with illicit drug use.  In the following section, the evidence 
on the treatment for substance dependence is outlined, before research that focuses on 




4. THE TREATMENT OF DRUG & ALCOHOL DEPENDENCE  
The treatments offered for drug and alcohol dependence are extremely diverse, reflecting 
the absence of consensus over the nature of the problem. There are also differences of 
emphasis between the UK and the US. American Federal agencies like the National 
Institute on Drug Abuse (NIDA) promote the view of drug dependence as a disease of the 
brain, and are funding major research programmes to establish the genetic basis of the 
disease, and to discover effective vaccines against marijuana and cocaine use (NIDA, 
1996). Treatment programmes based on religious principles, and on the 12 Steps of 
Alcoholics Anonymous and Narcotics Anonymous, are very popular in the US, and 
abstinence is widely seen as the only legitimate goal of intervention. In the UK, less 
importance is attached to the biological component of addiction, and there is more 
interest in cognitive behavioural treatments. The difference between the two countriesis 
partly due to the existence of a very large private treatment sector in the US; private 
addictions treatment is an extremely profitable business which has resisted systematic 
evaluation (Smeeth & Fowler, 1990). In contrast, the publicly funded NHS has often 
responded fairly rapidly to research on alcohol and drug dependence (Harrison, 1996). 
Harm Minimisation is accepted by the British as an acceptable goal for intervention, and 
the UK Departments of Health are committed to the adoption, wherever possible, of 
evidence-based practice (Lord President of the Council, 1995, 1998).  
 
Randomised controlled trials (RCTs) provide the strongest evidence of treatment 
efficacy, and there would appear to be no shortage of trials to inform a search for 
evidence-based practice. Up to the end of the year 2000, at least 39 RCTs had been 
conducted on acupuncture alone. But historically, the quality of RCTs in the addictions 
field has been poor (Breslin et al., 1997). Riet and colleagues (1990) used a checklist of 
18 predefined criteria of good methodology to examine the conduct of 22 RCTs of 
acupuncture. They found that not one of the 22 RCTs could be awarded more than 75 
points out of 100 for methodology, and over half earned less than 50 points. Breslin and 
colleagues (1997), reviewing the methodology of 61 alcohol treatment outcome studies 
published between 1989 and 1993, claimed that only a minority met even the most basic 
requirements of experimental studies. Until recently, reviews of treatment effectiveness 
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have been extremely selectiv , therefore, and studied a restricted number of trials which 
possessed acceptable methodology (Emrick, 1975; McCrady, 1991; Miller & Hester, 
1986).   
 
The methodological quality of controlled trials in the alcohol field has improved in recent 
years, although a number of serious reservations rema n about the design of many studies 
(Miller & Wilbourne, 2002; Moyer, Finney, & Swearingen, 2002; Moyer et al., 2002). It 
is also worth noting that the majority of trials focus on treatments for alcohol related 
disorders; there are relatively few RCTs concerned with drugs of dependence other tha  
alcohol or tobacco. Trials of treatments for drug dependence have largely concerned 
pharmacotherapy, chiefly aspects of methadone maintenance, or comparisons between 
methadone and buprenorphine. There are, for example, at least seven meta- nalyses 
dealing with the effectiveness of methadone, but none on psychotherapy (Barnett, 
Rodgers, & Bloch, 2001; Caplehorn et al., 1996; Farre et al., 2002; Glanz et al., 1997; 
Griffith et al., 2000; Marsch, 1998; West, O'Neal, & Graham, 2000).  
 
Although better conducted RCTs have been able to eliminate several lines of enquiry, 
such as electrical stimulation therapy, or the use of Risperid ne, Carbamazepine and 
Amantadine for the treatment of cocaine dependence (Georgiou et al., 1998; Grabowski 
et al., 2000; Kampman et al., 1996; Montoya et al., 1995), it is arguable that they have 
not produced unequivocal evidence in favour of any particular treatment. There is 
qualified support for pharmaceutical treatments such as the use of the opium antagonist 
Naltrexone as a way to counter the positive reinforcement obtained from heroi  use 
(Chick et al., 2000), and there is forty years of consistent evidence supporting methadone 
substitution as a harm reduction measure in cases of dependence on opiates.  
Pharmaceutical measures seem to work best when combined with psychological 
treatments, however (Chick et al., 2000). 
 
When psychological treatments are considered for alcohol dependence, the evidence 
favours behavioural treatments rather than psychodynamic and insight oriented 
individual, group or family therapy (Miller, Brown, & Simpson, 1995).  Among 
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behavioural treatments, there has been a shift away from approaches based on classical 
conditioning, like aversion therapy, which were popular in the 1960s but have not stood 
up to rigorous evaluation (Wilson, 1987), in favour of approaches like cognitive 
behavioural Coping Skills Therapy and Motivational Interviewing (Miller & Rollnick, 
1991; Project MATCH Research Group, 1997). There are also multiple well designed 
trials supporting Community Reinforcement, Behavioural Self Control Training, 
Behavioural Marital Therapy and Social Skills Training(McCrady, 1991; Miller, Brown, 
& Simpson, 1995; Miller & Wilbourne, 2002).   
 
Following the inconclusive results of Project Match (Project MATCH Research Group, 
1997), it is widely believed that the evidence has yet to emerge which would support the 
adoption of any one approach to treatment for alcohol dependence, like Cognitive 
Behavioural Therapy, over rivals like 12 Steps facilitation. However, Miller and 
Wilbourne (2002), in their meta-analysis of 361 treatment trials for alcohol-re ated 
disorders, claimed a clear advantage for behavioural approaches. Six of the ten treatments 
with the strongest evidence for effectiveness utilised some form of behavioural skills 
training, and three of these paid attention to social support networks (Miller and 
Wilbourne, 2002: 176). In contrast, 12 Steps approaches, like the Minnesota Method and 
mandatory Alcoholics Anonymous participation, did relatively badly. 
 
In the absence of agreement over the interpretation of the research evidence, treatments 
based on contradictory theoretical principles remain in common use.   The generally 
accepted view is that any treatment for substance dependence is better than no r atment 
(Raistrick, Hodgson, & Ritson, 1999). This is because all major treatment programmes 
can show a significant improvement over baseline measures of drug or alcohol-related 
problems among research subjects (Project MATCH Research Group, 1997). Such 
improvements are not necessarily related to the treatment on offer, however. In their 
classic study comparing in-patient treatment of alcoholism with brief intervention, Orford 
and Edwards (1977) showed that, when asked about reasons for their improvement, 
subjects rated other lif  events as more important than the treatment they received. This 
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raises doubts about the impact of specialised treatment, which may be only one of a 
number of changes occurring in people’s lives at the time when they seek help.   
 
Because of these difficulties, many have preferred to compare the results obtained by 
treatment with spontaneous remission, or the recovery from alcohol and drug dependence 
without formal treatment (Marshall, 1996). Babor (1995) argues that treatment is 
effective for alcohol dependence because only about one third of people might be 
expected to recover without professional help, whereas two thirds would recover 
following treatment. Such arguments depend on the way in which several key concepts 
are defined and operationalised, however.  Depending on how dependence and remission 
are defined, rates of natural recovery have ranged from 37% to 54% (Marshall, 1996). In 
the most recent Canadian studies, as many as three quarters of all problem drinkers in the 
community recovered without formal treatment, which compares favourably with the 
success rates for most therapies (Sob ll, Cunningham, & Sobell, 1996). 
 
On this evidence, there is little reason to think that intervention is superior to natural 
recovery, and a number of longitudinal studies have supported the view that formal 
treatment does not play a major role in recovery from alcohol and drug depe ence. As 
Vaillant (1995) concluded in relation to alcohol dependence, following his ground-
breaking 50 year longitudinal study of more than 600 men,  “… alcoholics recover not 
because we treat them but because they heal themselves” (Vaillant, 1995: 384).  
 
There are five reasons for believing that specialised treatment has a relatively limited 
role. First, the majority of people resolve alcohol and drug-related problems without 
professional help (Sobell, Cunningham, & Sobell, 1996; Vaillant, 1995). For many 
people, including some of those with the greatest severity of alcohol problems, treatment 
is not necessary for recovery (Bischof et al., 2001). 
 
Second, self-help manuals and mutual aid groups, like Alcoholics Anonymous and 
Narcotics Anonymous, are a marked feature of this field, either operating in conjunction 
with formal treatment or as an alternative to it. Mutual aid groups can help by providing 
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social support through a social network that is not centred on drug use (Nealon, Ferrari, 
& Jason, 1995). Since treatments of different kinds have relatively poor success rates in 
the absence of adequate levels of social support, it is clear that treatment is not sufficient 
for recovery. 
 
Third, there is ample evidence that quite brief interventions for alcohol dependence, such 
as a single meeting with a counsellor, can initiate change (Bien, Mill r, & Tonigan, 
1993). Indeed, the evidence from studies of cost effectiveness is that, on the whole, 
treatment success has an inverse relationship to cost (Holder et al., 1991). That is, the 
most expensive interventions for alcohol dependence, like in-patient treatment and 
residential rehabilitation, appear to be the least effective (Annis, 1986a; Holder et al., 
1991).  Brief interventions have been very successful with alcohol problems but are 
under-utilised with other drug problems. 
 
Fourth, despite frequent claims that success is linked to the length of stay in treatment, no 
consistent evidence has been found that increasing the length or intensity of treatment 
improves outcomes (Miller, 2000). Many residential programmes exclude from their 
evaluation all clients who withdraw prematurely, and base their success rates on the 
better motivated clients who complete the programme. Such practices are questionable, 
as the challenge in the addictions field is to find ways to help clients resolve ambivalence 
and improve their motivation (Miller & Rollnick, 1991). Well-motivated clients can 
usually recover without intensive intervention. 
 
Fifth, well-conducted studies like Project MATCH, which was a five year randomised 
controlled trial, involving over 1600 subjects, have shown that, although there are major 
theoretical differences in the rationale for different therap u ic approaches, they achieve 
broadly similar outcomes (Project MATCH Research Group, 1997). The client’s 
socioeconomic and psychiatric profile is a much better predictor of treatment outcome 
than is the kind or intensity of the treatment programme. Patients with better social 
support, and fewer psychiatric problems, do well in most treatments. 
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Also, therapist variables are also more important than theoretical perspectives (Miller, 
2000). In particular, the ability of therapists to empathise with clients seems to prdict 
success (Miller, 2000). Specialised treatment seems to be less important than many 
assume, therefore, although it is worth noting that it can make matters worse: it is 
probably easier for improper treatment to retard recovery than for proper treatment to 
hasten it (Emrick, 1975).  
 
As Vaillant (1995) argues, however, our inability to alter the natural course of a disorder 
does not mean that intervention should not take place. Vaillant us s the example of 
tuberculosis, where medicine was able to save lives by enhancing natural recovery, long 
before an effective cure was found. Progress may come from finding ways to strengthen 
resilience and promote the natural processes that foster recovery from alcohol and drug 
dependence. 
Studies of natural recovery have identified perceived social support as one of the most 
important factors associated with lifestyle change (Marshall, 1996: 155).  Social support 
is also one of most important predictors of success for people in treatment. As long ago 
as 1966, Vaillant showed that in New York, prison followed by parole was fifteen times 
more successful in promoting the resolution of drug problems than in-patient hospital 
treatment, which in those days was not accompanied by aftercare. What seemed to count 
was structured support in dealing with problems, in the environment in which they 
developed, alongside practical help with employment and accommodation (Vaillant, 
1966).   
 
Because of the US emphasis on biological research, studies of social support have been 
neglected in recent years, apart from research on the Community Reinforcement 
Approach, where support is contingent on compliance with an abstinence-oriented 
treatment regime (Smith, Meyers, & Miller, 2001). The inclusion of Social and 
Behavioural Network Therapy in the UKATT trials in the UK may represent a 
reappraisal of the significance of social intervention, certainly in Europe, and the 
development of more structured approaches to its provision (C pell  et al., 2001).   
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Such research is likely to prove crucial to the future success of prison aftercare.  As 
Burrows and colleagues (2000: 40) note, in commenting on the difficulties faced by ex-
prisoners:  “Many have housing and financial difficulties and even psychiatric problems. 
They may be released to either poor family support or indeed deeply dysfunctional 
families and friends”. For this reason, many agencies which started by taking an 
exclusively psychological approach to the provision of drug services have been ”obliged 
to widen their remit to providing a general support function – such as helping ex-
prisoners with obtaining housing, social security benefits” (Burrows et al., 2000: 40). 
This is often described as providing a ‘holistic’ approach, when it might be better 
described as  reorientation to the fundamental core of successful intervention in alcohol 
and drug problems. 
 
Another reason for optimism, despite the modest success rates associated with specialised 
treatment, is that abstinence has often been held to be the sole criterion of suc ess. This 
ignores the fact that even if intervention only manages to reduce the frequency of relapse, 
it may serve to lengthen the lifespan and can therefore be justified. Treatment often has a 
number of positive outcomes but the “substantial level of improvement in ‘unremitted’ 
clients tends to be overlooked when outcomes are dichotomized as successful or 
relapsed” (Miller, Walters, & Bennett, 2001). In order to decide whether treatment is 
worthwhile it is necessary to adopt a more sophisticated approach to evaluation, one that 
recognises that the goal of intervention is broader than abstinence. This can be achieved 
through the use of economic methods of appraisal such as cost benefit, cost offset and 
cost effectiveness analyses. These can determine whether the cost of treatment is 
outweighed by its benefits, whether the cost is offset by a reduction in other costs, such as 
crime, and which kinds of treatment provide the most benefit for a given level of 
resource, or which provide equivalent benefits for least cost (Godfrey, 1992).  
 
There is now a growing body of evidence, from the US and from Britain, that the 
treatment of drug dependence is economically efficient; that is, that the benefits of 
treatment outweigh the costs.  A review of 18 American cost-benefit studies showed 
consistent positive economic returns to society (Cartwright, 2000). In the UK, post 
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treatment reductions in health care costs and in offending behaviour mean that 
intervention is cost effective even when problem drug use continues (Gossop, Marsden, 
& Stewart, 1998). In a study of 221 opiate addicts receiving six months of methadone 
treatment in East London, for example, the cost of treatment (£960) was more than offset 
by the reduction in illegal earnings over the same period (between £2,142 and £7,878) 
(Coid et al., 2000). The US research on drug treatment in the criminal justice system, 
which is much more extensiv  than that in the UK, shows that drug treatment reduces 
criminal activity, and hospital admissions, while improving health status. Overall, 
reductions in costs to the criminal justice system of up to 20% have been found 
(Harwood et al., 1988). For this reason, the Prison Service has calculated that even 
relatively modest reductions in offending would make treatment programmes in prison 
economically efficient. If 3,000 prisoners a year benefited from treatment and ceased to 
offend, there would be a net benefit to society, even though this number represents less 
than 2.5% of the annual intake of prisoners (Grav tt, 2000). 
 
Summary  While formal treatment may not play a m jor role in promoting abstinence 
from alcohol and drug use, intervention is economically efficient because the benefits 
from reductions in offending behaviour and improvements in health status outweigh the 
costs of treatment. This is likely to be evenmore true in the prison system, where drug 
use creates a range of specific problems for security, prisoner and community health, and 
for the achievement of the Prison Service’s aims and objectives. The following section 
outlines the treatments available within the prison system, and the evidence for their 
effectiveness. Then, current treatment regimes are discussed, along with problems of 




5. DRUG SERVICES IN PRISON 
Most British research on the prison system ha  focused on how the diversion of drug 
offenders from custody is cost effective (Mauser, Van Stelle & Moberg, 1994), and on 
the public health risks associated with injecting drug use in prisons, rather than on how 
prison-based treatment can be improved (Freudenberg, 2001; Malliori et al., 1998; Martin 
et al., 2000; Shewan et al., 2000).
 
Clearly, treatment in prison will never be a viable alternative to treatment in the 
community, because of the high cost of imprisonment: the annual cost per prisoner in the 
year 2000 was £27,566 (Home Office, 2001). Given that many offenders have severe 
problems with illicit drugs, however, it would be unethical not to utilise the opportunity 
that imprisonment provides for treatment and rehabilitation (Brooke et al., 1998; Keene, 
1997; Maden, Swinton, & Gunn, 1992).  Indeed, because the expense of imprisonment is 
a sunk cost, some forms of residential treatment, which might not be economically 
efficient in the community, become feasible for prisoners. The true costs of a prison 
therapeutic community, for example, are the marginal costs; that is, the difference 
between the cost f he standard prison regime and the therapeutic regime. An economic 
evaluation would consider whether the total benefits, in terms of the number of prisoners 
rehabilitated, exceeds the cost at the margin of providing the therapeutic community, or 
an alternative treatment. Information about marginal costs and benefits is not available to 
policy makers currently, and there is, therefore, an urgent need to conduct independent, 
systematic and careful evaluations of prison treatment. 
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6. THE EVIDENCE BASE FOR PRISON TREATMENT  
The drug services available within the British prison system range from 12 Steps 
facilitation (e.g. Norwich), acupuncture ( .g. Bristol), Cognitive Behavioural Treatment 
(e.g. Wormwood Scrubs), educational programmes (e.g. Full Sutton), groupwork (e.g. 
Elmley), relapse prevention training (e.g. Askham Grange), therapeutic communities (e.g. 
Channings Wood) to pharmacological treatment including methadone maintenance 
(Gravett, 2000; Burrows et al., 2000). Non-directive counselling and Motivational 
Interviewing are probably the most common interventions. Although no outcome 
evaluations are available from the prisons involved, it is possible to refer to the US 
evidence on treatment effectiveness, provided caution is exercised in generalising from 
the American to the British situation, because of differences in culture, the policy context, 
and the health and penal systems. Although no substitute for outcome evaluation research 
in British prisons, the following section summarises briefly the largely US research on 
the treatment programmes that are in common use within UK prisons. 
 
 
6.1 12 Steps Facilitation 
All 12 Steps programmes derive ultimately from the methods developed by the self-help 
group Alcoholics Anonymous, and its later offshoots like Narcot cs Anonymous. 
Independent evaluations of 12 Steps programmes are thin on the ground, but the largest 
comparative study, conducted by Project MATCH, found that its results were comparable 
to cognitive behavioural approaches, which have been much more extensively valuated 
(Project MATCH Research Group, 1997).   
 
Alcoholics Anonymous has always refused to become involved in the evaluation of 
effectiveness and will not usually agree to the randomized allocation of clients. Some 
randomized studies have been conducted in the US, however, using clients mandated to 
attend Alcoholics Anonymous meetings by the American courts. A meta-analysis of 21 
controlled trials of Alcoholics Anonymous found that those trials that had been able to 
adopt the randomized allocation of subjects obtained less favourable results than the non-
randomized trials, although this may have been a selection bias due to the inclusion of 
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coerced subjects in the randomized trials (Kownacki & Shadish, 1999).  Kownacki and 
Shadish (1999) found attendance at Alcoholics Anonymous meetings to be worse than no 
treatment or alternative treatment, while residential 12 Steps treatments had no advantage 
over alternative forms of residential treatment.   
 
Only seven studies of Alcoholics Anonymous met the methodological criteria to be 
included in Miller and Wilbourne’s (2002) meta-analysis. Most used clients mandated to 
attend Alcoholics Anonymous meetings by the courts. Alcoholics Anonymous was one of 
the treatments with the least evidence for effectiveness, ranked in the last ten of 46 
different treatment modalities. Neither did the Minnesota Method or other forms of 12 
Steps faciliation, receive strong support. 
Although the 12 Steps movement insists on its non-denominational status, always being 
careful to refer to “God as you understand Him” eight of th  12 steps refer to God, and 
the movement has its origins in the Oxford Movement and in American Midwestern 
Christianity. Although it has been exported all over the world, Alcoholics Anonymous is 
culturally specific. It has been most successful in Protesta t countries, with the notable 
exception of the Irish Republic. In recent years, the US court practice of mandating those 
guilty of alcohol-related offences to attend Alcoholics Anonymous meetings has been 
declared unconstitutional, because of the religious basis of Alcoholics Anonymous 
(Harrison, 1996). 
 
6.2 Acupuncture  
Over ten years ago, Riet and colleagues (1990) undertook a meta-analysis of 22 trials of 
acupuncture with three substances: tobacco (15), heroin (5) and alcohol (2). They 
concluded that there was no support for the claim that acupuncture was an effective 
treatment for addiction, although they conceded that it may have a useful placebo effect 
during drug withdrawal (Riet, Kleijnen, & Knipschild, 1990).  In Miller and Wilbourne’s 
more recent (2002) meta-analysis, only three trials of acupuncture met the strict inclusion 
criteria, but they received relatively high cumulative evidence scores, so that acupuncture 
was judged to have stronger support than many pharmacotherapies, like the use of 
serotonin antagonists. Acupuncture appears to be gaining in acceptance, and on this 
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evidence those prisons that have introduced acupuncture treatment regimes, like HMP 
Bristol, would seem to be justified. 
 
6.3 Behavioural Approaches 
Miller and Wilbourne (2002) found that behavioural skills training – including social 
skills training, community reinforcement, behaviour contracting, self monitoring 
techniques and behavioural marital therapy - dominated the ‘top ten’ treatment modalities 
in their meta-analysi , having the strongest evidence for effectiveness. This may reflect 
the greater likelihood that behavioural methods will be evaluated. As Miller and 
Wilbourne point out, the high ranking of behavioural treatments does not necessarily 
mean they are more effective than other approaches, simply that the evidence for their 
effectiveness is stronger.  Behavioural skills training shared two features with other high-
ranking treatments like brief interventions and Motivational Interviewing (often 
considered to be a cognitive behavioural treatment but here considered separately): an 
emphasis on self- f icacy and attention paid to motivation. Many of the leading 
treatments also featured some measure of intervention in the client’s social support 
system. 
 
The results from trials of other behavioural therapies are less clear-cut, although at least 
one approach, cue exposure, appears to show some potential (Carter & Tiffany, 1999; 
Conklin & Tiffany, 2002). There is rather more evidence in favour of Cognitive 
Behavioural Therapy. The rationale for using cognitive behavioural principles to help 
people who have drug problems was summarised by Miller and Brown (1997). They 
argue that drug using behaviours follow general behavioural principles, and that problem 
drug use frequently occurs within a broader cluster of psychological problems. For Miller 
and Brown, cognitive-behavioural principles are of demonstrable value not only in 
motivating change in drug using behaviours, but in helping people with co-occurring 
problems such as anxiety states and depression.   
 
There is a larger research base on Cognitive Behavioural Therapy than on any alternative 
approach in the addictions field, and it has a consistent record for effectiveness. There is 
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also North American research on t e use of cognitive behavioural programmes within the 
criminal justice system, largely by the probation service, which suggests that it is an 
effective way to help offenders (Vennard, Hedderman, & Sugg, 1997). Yet although over 
30 English probation areas use cognitive beha ioural programmes, there appears to have 
been no British evaluative research.  Research on the use of cognitive behavioural 
programmes within the prison system is surprisingly limited: three projects were reported 
to be underway in the US in 1997, but have not resulted in publications yet (Edens, 
Peters, & Hills, 1997).  
 
6.4 Counselling 
Rogerian non directive counselling is popular among service providers, particularly those 
in the non-statutory sector (Hunt, Mellor, & Turner, 1992).  Despite its popularity, the 
evidence that it helps people with alcohol and drug problems is not strong (Miller & 
Hester, 1986). The evidence supporting its use within the criminal justice system system 
is even more limited. In Egg and colleagues’ (2000) meta-analysis of treatment in the 
German criminal justice system, four studies of programmes offering counselling for 
drink-driving  offenders obtained results which, while not statistically significant, were 
considered promising enough to warrant further research. However, the failure of 
psychotherapy and counselling to make an impact on drug problems in all previous 
studies should counsel caution.  
 
6.5 Educational programmes 
Although drugs education remains popular with policy makers, particularly when 
targeted at school children, the evidence that providing knowledge or seeking to change 
attitudes is an effective way to modify behaviour has always been lacking (Baldwin, 
1990; Raistrick, Hodgson, & Ritson, 1999). Although over 2,000 probation clients 
graduated from alcohol education courses in the 1980s, for example, and the approach 
became the ‘treatment of choice’ for drink driving offences in the UK, no controlled 
evaluation was undertaken and evidence of effectiveness was meagre (Baldwin & 
Heather, 1987). Pilot studies of prison educational courses in Australia and in Britain 
have occasionally shown promise (Crundall & Deacon, 1997; MacMillan & Baldwin, 
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1993), but a meta-analysis of research on the impact of treatment programmes in the 
German criminal justice system, between 1968-1996, found that educational programmes 
had no effect in reducing reconviction rates (Egg et al., 2000).   
Perhaps reducing reconviction rates is an over-ambitious target for educational 
programmes, however. Those working within Prochaska and DiClemente’s (1986) 
conceptual framework would argue that education might be appropriate for those 
offenders who were p -contemplative, in that they had yet to make a connection between 
their drug use and the problems they were experiencing in life. From this point of view, 
educational programmes often suffer from being unfocussed, and might best be targeted 
at those who were in need of ‘consciousness raising’. They should seek to provide 
specific information, like the health information on preventing the transmission of 
HIV/AIDS, rather than general exhortations, like “heroin screw you up”. Enabling clients 
to move from a pre-contemplative to a contemplative stage increases the likelihood of 
eventual behaviour change substantially (Prochaska and DiClemente, 1986). In support of 
this argument is the impact of information campaigns by the Royal Medical Colleges on 
cigarette smoking, which have resulted in dramatic reduction in smoking prevalence 
since 1972, despite the falling price of cigarettes in real terms over most of this period 
(Raistrick, Hodgson, & Ritson, 1999). 
 
6.6 Group work 
Group work has been favoured in the treatment of substance problems for some time, 
partly for reasons of cost limitation, and it has been in use within the English prison 
system since the 1960s (Glatt, 1982). Like psychoanalysis, it is not an approach that has 
been characterised by frequent attempts at outcome evaluation. There have been 
occasional outcome studies of group work within the prison system, usually of 
programmes for those sentenced for alcohol- elated offences, and they have received 
mixed results (Berlinger, 1987; Panepinto et al., 1982) In Dugan and Everett’s (1998) 
trial, 145 prisoners with problems of drug dependence were assigned randomly to a 
treatment group and a control group.  Treatment involved 72 hours of group therapy. 
Reconviction rates 2 years after release indicated no significant difference between the 
treatment and control groups. Group work is often a key component of therapeutic 
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communities, however, which have received positive evaluations, and so it may be 
considered as contributing to the apparent success of prison therapeutic communities (see 
below).  
 
6.7 Motivational Interviewing 
Motivational Interviewing is a non-confrontational, research-based method of helping 
clients to resolve ambivalence and enhance their motivation to change (Miller, Benefield, 
& Tonigan, 1993; Miller & Rollnick, 1991). The evidence for its effectiveness is strong, 
particularly with clients who are angry and resistant to change (Project MATCH 
Research Group Research Group, 1997; Project MATCH Research Group et al., 1997). In 
Miller and Wilbourne’s (2002) meta-analysis, Motivational interviewing ranked second, 
as one of the treatments with the strongest evidence for effectiveness. It is being 
evaluated currently in the UK as part of the UKATT trials (Copello et al., 2001). 
Although its use in prison has more justification than most drug treatments in general use, 
there is no specific literature on its use within the prison system.  
 
6.8 Pharmacotherapy 
The pharmacological treatment that has had most application within the criminal justice 
system has been the use of the long acting opiod methadone hydrochloride as a substitute 
for heroin. Despite initial anxieties about its use for opiate detoxification within a prison 
setting (Jeanmonod, Harding, & Staub, 1991) it has been adopted for this purpose in at 
least seven countries, including the UK (Dolan & Wodak, 1996). The British 
Government has allocated over £10 million to improve detoxification facilities in local 
prisons, and the Prison Service aims to bring the standard of medical care for drug 
detoxification into line with that available in the community (Gravett, 2000). Under the 
recommended detoxification regime, prisoners eceive decreasing doses of oral 
methadone over a seven-day period, minimising the discomfort of withdrawal and the 
risk of illegal drug use, or in some cases of suicide.  In some prisons, such as HMP 
Lindholme, lofexidine hydrochloride is used in place of methadone (Gravett, 2000).  
Lofexidine is a non-opiate treatment for opiate withdrawal which, while it may be less 
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effective than methadone in the early stages, has less serious side effects (Bearn, Gossop,
& Strang, 1996). 
 
There is good evidence that methadone maintenance has a positive impact on crime rates, 
and this has been largely responsible for optimism about the benefits of treatment for 
drug using offenders (Coid et al., 2000). Methadone maintenance attracts and retains 
more heroin injectors than any other form of treatment (Dol n & Wodak, 1996). In the 
US, Barnett (1999) showed that for every year of life that is saved by providing 
methadone to heroin addicts, an additional $5,915 in treatment costs were incurred, 
giving methadone maintenance a cost-effe tiveness ratio of less than $10,000 per-life 
year, which is much lower than that of many common medical therapies. Nevertheless, 
there has been reluctance to consider its use in prison, despite its potential for reducing 
injecting drug use and the transmission of blood borne diseases (Dolan, Hall, & Wodak, 
1998; Dolan, Wodak, & Hall, 1998).   
 
In an attempt to stop the cycle of prison detoxification followed by relapse on release, 
with the attendant risk of death from overdose, a methadone maintenance programme 
was established at Rikers Island prison in New York, with a post-release referral to a 
community methadone programme (Magura, Rosenblum, & Joseph, 1992). A total of 250 
prisoners, who were not on methadone maintenance on arrest, were randomly selected for 
the prison programme, and the preliminary evaluation was encouraging in terms of 
treatment retention, reductions in drug use and in high-risk be aviours for HIV 
transmission. Similarly, a comparison of prison and community methadone programmes 
in Australia showed that while methadone succeeded in reducing injecting drug use in 
both locations, prisoners injected less frequently than community patients (Darke, Kaye, 
& Finlay, 1998). Those who did inject in prison had higher levels of equipment sharing, 
however. 
 
In all studies of prisons conducting methadone maintenance, there has been a positive 
effect on injecting drug use both within prison and on release. In Dolan and colleagues’ 
(1998) study in New South Wales, 185 injecting drug users who had been recently 
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released from prison were interv ewed about drug use and syringe sharing. Self-reported 
injecting risk behaviours were compared in prisoners who had received either 
counselling, methadone detoxification or methadone maintenance in prison. Subjects who 
had been maintained on methadone rep rt d a significantly lower prevalence of heroin 
injection and syringe sharing, and they obtained lower scores on an HIV Risk-taki g 
Behavioural Scale than subjects who received counselling or methadone detoxification. 
This study confirms that, despite the difficulties posed for prison regimes in having 
prisoners receive powerful analgesic drugs while in custody, methadone maintenance can 
reduce injecting risk behaviour in prison and the risk of heroin overdose on release.  
 
6.9 Relapse Prevention Training 
It is generally acknowledged that detoxification is not a particularly difficult stage of 
treatment for substance dependence; what is much more problematic is preventing 
relapse once prisoners are released. Relapse prevention is a cognitive behavioural 
approach to training clients in ways to anticipate and manage the circumstances which 
might lead to relapse (Annis, 1986b; Marlatt & Gordon, 1985). A meta- nalysis of 27 
published and unpublished studies of relapse prevention, representing a sample of 9,504 
participants, indicated that it is generally effective, particularly for alcohol problems 
(Irvin et al., 1999). Not only does relapse prevention prolong the intervals between 
relapses, it reduces the severity of relapses once they occur (Carroll, 1996). Its use within 
pre-release training courses in prison can be justified, therefore, although nce again 
there is not a specific literature on the outcome of relapse prevention training within the 
prison system.  
 
6.10 Therapeutic Communities 
Residential treatment is one of the least cost effective options for drug dependence 
(Annis, 1986a ; 1987). When compared directly with day care, residential treatment 
offers few advantages, and my even be less effective: social learning theory suggests 
that it would be better to modify behaviour in the environment in which problems arose. 
In Miller and Wilbourne’s (2002) meta-analysis, milieu therapy and therapeutic 
communities received little support from controlled trials, although therapeutic 
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communities were represented by only one study, the others having been judged 
methodologically poor. 
 
Despite these unpromising results, it is being claimed that therapeutic communities in 
American prisons have shown consistent reductions in reconviction rates and in drug use 
(Condelli & Hubbard, 1994; Eisenberg & Fabelo, 1996; Field, 1992; Inciardi et al., 1997; 
Nielsen, Scarpitti, & Inciardi, 1996). One therapeutic community which has been 
extensively researched is the Donovan prison therapeutic community and aftercare 
programme in San Diego, California (Wexler et al., 1999). Subjects were randomly 
assigned to a treatment and a no-tre tment control group, taken from a waiting list of 
prisoners who had volunteered to participate.  Reductions in reconviction rates of more 
than 40 per cent at 12 months and more than 50 per cent 24 months after release from 
prison were found, but only for the group that completed both the prison and aftercare 
programme (Wexler et al., 1999).  
 
As in other studies of therapeutic communities, success was claimed for prisoners 
completing treatment, and prisoners who dropped out were excluded from the analysis. 
As De Leon et al. (2000), note:  “most admissions leave treatment prematurely, 
particularly in the first months after admission.” In Eisenberg and Fabelo’s (1996) study 
of a Texas prison therapeutic community, the authors state explicitly that large numbers 
of prisoners did not complete treatment, and these prisoners had reconviction rates 
comparable to the control group.   
 
Whether this is seen as a problem or not may depend on the reasons why some prisoners 
can be retained in treatment while others drop out. De Leon and colleagues (2000) make 
it clear in their study of a prison therapeutic community that those retained in treatment 
had higher motivation. Yet most prisons are likely to have large numbers of offenders 
who are ambivalent about changing their behaviour and have fluctuating levels of 
motivation, suggesting that if the therapeutic communities option is adopted, treatment 
resources are being concentrated on a small percentage of the prison population. Higher 
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overall success rates would be achieved by interventions that seek to help prisoners 
resolve issues of motivation, like Motivational Interviewing (Miller & Rollnick, 1991).   
 
In Strauss and Falkin’s (2000) study of a therapeutic community for women prisoners, 
those who dropped out reported conflicts or disagreements with the programme’s rules.  
Since many American therapeutic communities adopt an extremely confrontational 
stance towards residents, such disagreements may be due to a large number of women 
resisting confrontational tactics. There is some evidence that a irective-confrontational 
therapeutic style results in significantly more resistance from clients, which in turn 
predicts poorer outcomes (Miller, Benefield, & Tonigan, 1993).  In these circumstances, 
retention problems probably stem directly from a therapist style that is ineffective.  
Higher overall success rates would be achievedby working constructively with client 
resistance. 
 
Almost all of the successful US prison therapeutic communities are linked to an aftercare 
programme. For example, the Oregon therapeutic community included an aftercare 
component that continued at least six months into the client's parole (Field, 1992). 
Inciardi and colleagues proposed a seamless transition between prison and community in 
Delaware, involving three stages: 
 
The primary stage should occur in prison, where there is the time and oppor unity 
for comprehensive treatment. The second stage is a transitional (therapeutic 
community), providing a therapeutic and prosaic milieu for individuals on work 
release.  The third stage, when the client is back in the free community, involves 
counseling, group therapy, and participation in transition program activities. 
(Inciardi, Lockwood, & Martin, 1994).   
 
While such an integrated, multistage structure should guard against the problems 
experienced in Britain through the breakdown of aftercare arrangem nts, it raises 
questions of cost. This issue has not been addressed adequately in the evaluations of the 
three major prison therapeutic community projects in the States: the Kyle New Vision 
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programme in Texas (Hiller, Knight, & Simpson, 1999); the KEY-CREST programme at 
Delaware (Inciardi, Lockwood & Martin, 1994); and the Amity programme at Donovan 
prison in San Diego (Wexler et al., 1999).   
 
In the Kyle New Vision programme in Texas, a large number of offenders did not 
complete treatment, and these people had reconviction rates comparable to non 
participants (Eisenberg & Fabelo, 1996; Hiller, Knight, & Simpson, 1999). The group 
who completed only the prison programme appeared to do better than the control group at 
the 13-23 month follow up, although the difference was not statistically significant (36% 
reconvicted against 42% of the control group). Neither group did as well as the prisoners 
who completed the ‘half-w y house’ programme in addition to the prison therapeutic 
community (30%) (Hiller, Knight, & Simpson, 1999). 
 
In the Delaware project, the evaluation also focused on the therapeutic community i  
prison and a "transitional" therapeutic community outside of prison (Martin, Butzin, & 
Inciardi, 1995). Six months after release, a control group, who had not participated in any 
form of treatment, was compared to groups who had participated in the therapeutic 
community in prison only, the transitional therapeutic community onl , or both 
therapeutic communities. Both groups who attended the transitional therapeutic 
community had significantly lower rates of drug use and reconvictions, but the reductions 
among those who had only attended the prison therapeutic community were modest, and 
statistically significant only when adjusted for baseline differences (Martin, Butzin, & 
Inciardi, 1995). In Wexler and colleagues’ (1999) study of the Amity prison therapeutic 
community in San Diego, the reconviction rates of both drop-outs and those who had 
completed the prison-based programme were within 2 percentage points of the control 
group; only those who also attended a transitional therapeutic community after release 
showed substantial gains.   
 
The fact that the two evaluations which included a group attending only a ‘half-w y 
house’ programme found that this group did as well as those who had intensive treatment 
in both prison and the community raises the possibility that limiting provision to a 
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transitional therapeutic community would be more cost effective than providing a 
multistage structure. This issue was not addressed by either research team. 
 
In the US, prison therapeutic communities are g nerally viewed as a success for people 
with substance problems (Wexler, 1995). Because researchers have been allowed to 
exclude prisoners who drop out, however, it could be argued that a misleading picture has 
been given of the effectiveness of this intensive form of treatment. In the UK, there has 
been little interest in evaluating prison therapeutic communities, with the possible 
exception of HMP Grendon, which specialises in people with personality disorders. The 
work of the Grendon therapeutic community has been evaluated over a seven year period 
and shown to result in a marginally lower reconviction rate (Taylor, 2000). Although 
Wormwood Scrubs and other British prisons have considerable experience in running 
therapeutic communities for prisoners with substance problems, there has not been any 
sustained research to address the question of effectiveness. The Prison Service has 
already decided to expand the provision of therapeutic communities for prisoners with 
substance problems, however, and this should present the opportunity for a thorough 
outcome evaluation to be conducted. If US research is taken into account, at least one 
prison programme should be linked to a transitional therapeutic community, possibly in 
the form of a prison-based day release scheme, together with a structured aftercare 
programme.   
 
In order to facilitate comparisons with prior research, the evaluation should include: a 
control group, which receives only brief advice in the course of a pre-release scheme plus 
aftercare provided by the probation service, or by a community-based drugs agency; a 
group which experiences both prison and community-based treatment; a group which 
only attends the prison therapeutic community, plus aftercare; and a group which only 
experiences the transitional therapeutic community. Full economic costings should be 
undertaken, to enable policy makers to answer the question of whether the marginal costs 
of providing the prison therapeutic community are justified by the additional benefits in 
terms of reductions in reconviction rates and other outcome measures. Given the 
longstanding criticisms of reliance on reconviction rates as a c iterion of success, a range 
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of outcome measures, including frequency of drug problems and health care costs, should 
be adopted.  
 
7. CURRENT TREATMENT REGIMES  
Although a survey of UK prison treatment for alcohol dependence was undertaken in 
1989, and found provision to be haphazard and not centrally coordinated (McMurr n & 
Baldwin, 1989), there has been no equivalent census of drug services in British prisons. 
In the year 2000, the provision of drug services was reported to be uneven, both in terms 
of the type of programme offered and the number of places available, and some prisons 
were said to lack proper detoxification facilities, but there is no specific information on 
current provision (Burrows et al., 2000). 
 
Between 1995 and 1997, the Prison Service piloted 21 treatment programmes in 19 
establishments (Gravett, 2000: 131). These programmes were evaluated by private 
consultants PDM Consulting Ltd in 1998. PDM Consulting’s recommendations were 
managerial rather than clinical, and in their focus on issues of process, like coordination, 
were of a predictable nature. They advocated improved coordination with Area Drug 
Coordinators, the NHS, probation and social services and other agencies, for example, 
and the continual improvement of existing treatment programmes.  
 
Despite the Prison Service’s acceptance of the latter recommendation, and its 
commitment to the provision of effective services for prisoners with drug problems 
(Gravett, 2000), there has been little evaluation of hose services.   Although there has 
been research on the effectiveness of prison-based treatment programmes in the US (see 
below), there are no published, methodologically rigorous evaluations of the 
effectiveness of drug services in UK prisons. The oly data on treatment outcomes that is 
available was collected in the context of examining prison throughcare, and it is should 
be noted that the prisoners’ experience pre-dates th  introduction of the CARAT initiative 
by the Prison Service in 1999, which may ave resulted in significant improvements to 
services (Burrows et al., 2000). 
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Although Burrows and colleagues did not set out to examine the evidence for treatment 
effectiveness, their study is worth examining in detail because of the absence of specific 
outcome evaluation research in British prisons. One limitation is that their study relied on 
self-report data, though in some cases this was supplemented by questionnaires sent to 
probation officers. In addition, focus groups with prisoners and ex-pri oners were 
conducted in a small number of establishments. Another limitation is that te authors 
relied on a 3-4 month follow up, though provision was made for a later study of 
reconviction rates. A 4 month follow up will give a more favorable picture of tr atment
outcomes than follow ups conducted at either one or two year intervals, and would not 
normally be accepted as valid in the evaluation of alcohol or drug treatment services 
(Costello, 1980).   
 
The authors succeeded in tracking 112 ex-prisonrs out of an initial sample of 170 who 
were released between October 1998 and January 1999. This represents an acceptable 
response rate of 66 per cent. The study was not intended to be used to examine the 
effectiveness of specific treatment approaches, as the sample included prisoners from 17 
different prison service establishments (15 prisons, 2 Young Offender Institutions), who 
received a variety of different interventions.  It provides some feedback on different 
interventions, as ex-prisoners were asked their views on whether the treatment they 
received had been helpful, but the numbers in most groups are so small that no 
significance can be attached to the results, as the authors themselves acknowledge.  
 
The principal motivation for prisoners seeking tratmen  was reported to be abstinence 
(44%).  
 
But 23 per cent wanted to continue to use drugs while keeping their drug use 
under control and a further 20 per cent wanted to reduce the harm that they could 
cause themselves and those close to them. The remaining 13 per cent gave a 
variety of other reasons or simply did not give a specific reason for seeking 
treatment. 
(Burrows et al., 2000: 24) 
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It is not uncommon for clients to have differing motivation like this, and most 
community-based drugs agencies would negotiate the goals of intervention with the 
client.  In the prison system, however, the focus of all treatment programmes is on 
abstinence from drugs (Burrows et al., 2000). Other goals, like harm reduction, do not 
seem to be considered legitimate. This may be due to anxiety about colluding with law 
breaking, an issue with which the probation service attempted to come to terms in the 
1980s. There is a clear need for this de factopolicy to be reconsidered, as most of 
evidence for the effectiveness of drug treatment in the criminal justice system relates to 
interventions aimed at harm reduction, like methadone maintenance. 
 
Ninety per cent of ex-prisoners reported that their treatment had helped them, although 
half of these only considered it helped them ‘a little’ (Burrows et al., 2000: vi). Given 
that the goal of intervention was abstinence, the overall success rate was not impressive: 
four months after release, 14% said they had stopped taking drugs. Of those still using, 
the number taking heroin daily fell by 21 percentage points (from 66% of the sample to 
45%) and their spending on illicit drugs had more than halved, to about £275 per week. 
Although this is a definite gain, it is worth emphasising that the follow up took place 3-4 
months after release, nd the likelihood is that there would be a higher relapse rate by the 
one and two year stages.   
 
These are poor results, probably due to the fact that the interventions sampled ranged 
from those with little evidence of effectiveness, like educational progr mmes, to those 
with good evidence, like Motivational Interviewing. It is likely that the average success 
rate would be lowered by a number of poor performers. Moreover, the survey found 
prisoner aftercare to be sporadic or worse, with about half of the sample homeless, and 
only 16% in employment, four months after leaving prison (Burrows et al., 2000). This is 
regrettable, because in the absence of social support few treatment programmes have 
been found to be successful. The neglect of prison aftercare by the probation service is 
surprising, in some ways, given that its crucial role in supporting a change in problem 
drug use has been known for over 30 years (Vaillant, 1966; Inciardi et al., 1997). The 
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probation service has no statutory obligation to provide throughcare and aftercare for 
prisoners serving sentences of less than 12 months, however, which will include many of 
the offenders serving sentences for drug-related acquisitive crimes. Also, the priority for 
throughcare is given to clients posing an identifiable risk, interpreted as ‘danger to the 
public’ (Burrows et al., 2000). Relapse into drug use is not usually seen as a danger to the 
public. A recent joint development between the prison and probation service, OASys, 
aims to provide a more strategic nd systematic basis for assessing prisoner’s risks and 
needs. 
 
Such research is not without its problems. The evaluation of drug treatment programmes 
in prison is even more difficult than in the community. In add ion to the difficulties 
encountered in all evaluations of drugs treatment, such as disagreement about treatment 
goals and about the measurement of outcomes, must be added some problems that are 
intrinsic to the prison system. For example, court appearances, prison transfers, security 
considerations, maximizing the use of cell space and staff shortages may m k  it difficult 
to control movement into and out of prison-based treatment programmes (Lurigio & 
Swartz, 1994). In addition, client data may be difficult to obtain in some prisons, because 
record keeping for research purposes is given a lower priority.  Also, aftercare may be 
perfunctory, which would undermine the success of the prison treatment programme; 
and, unless long-term follow-up can be assured, the evaluation of outcomes will be 
problematic. Yet contact with researchers may be unwelcome to ex-prison rs. Many of 
those who have tried to track ex-prisoners have been unable to contact more than a third 
of their initial sample, although Burrows and colleagues (2000) have shown that, with 
persistence, a response rate in excess of two thirds can be achieved.   
 
A further caveat is that the results obtained from evaluating prison-based 
treatment cannot be compared directly with community-based interventions, 
because the prognosis for the two client groups is different. Prisoners are more 
likely to have lower socio-economic status, to have problems of greater severity 
and to be less motivated to change their behaviour than help-seeking clients in 
the community (Guyon et al., 1999). In other words, they are more likely to be 
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pre-contemplative, in Prochaska and DiClemente’s (1986) terms, and will not 
have been actively considering changing their behaviour before imprisonment.  
These factors are all associated with a lower rate of success.  
 
Gaes et al (1999) highlighted a number of methodological flaws in their meta-analys s of 
prison-based research. One problem is found in studies comparing the outcomes for 
prisoners that received treatment and who received post-release c mmunity supervision 
orders, and untreated prisoners who had shorter supervision periods following release. By 
comparing the treatment group with a control group that receives less support, results are 
biased in favour of finding a treatment effect. Similar methodological flaws can be found 
in the work of Hubbard et al. (1997) and Martin and Player (2000), who compared 
prisoners who completed a programme, with those who were on waiting lists, or had 
dropped out. This will bias the results, as those who drop out of treatment may be more 
likely to relapse.  
 
Gaes and colleagues also found evidence of selection bias. Some procedures only choose 
particular prisoners for a programme, whilst other procedures influence who remains on a 
programme. Another difficulty in comparing programmes is that the programme content 
is rarely described in detail to outsiders (Gaes et al., 1999). 
 
In addition, prison is not always a supportive environment for those who wish to abstain 
from drug use. The availability of drugs in prison, boredom, the experience of 
confinement, which is known to lead to maladaptive behaviour among the vulnerable,
and the absence of psychosocial resources that are known to promote lifestyle change, 
like social support, are all negative factors (Swann & James, 1998). Prisons are reported 
to differ quite markedly, however, in terms of regime characteristics, leading to large 
variations in levels of boredom and disaffection, and in the vailability of illicit drugs to 
prisoners. In 1998, for example, the rate of positive random drug testing varied, in 
dispersal prisons, from 1.2% at Wakefield to 17.7% at Frankland; in Category B prisons 
it ranged from 1.3% at Albany to 30.7% at Lowdh m Grange; and in Category C prisons 
from 0.7% at Blantyre House to 41.9% at Featherstone (Gravett, 2000: 59).   
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These differences may be due to divergence in meeting targets for the use of mandatory 
drug testing (Edgar & O'Donnell, 1998), the geographic location of the prison, the 
number and deployment of drug detection dogs and CCTV, proactive search 
programmes, the security status of prisoners, and the vigilance of staff, as well as the 
priority given to drug policies within the prison (Gravett, 2000).  Increasingly, prisons are 
providing voluntary testing units or drug-free wings for those who agree not to use drugs. 
Participation in a drug free wing is subject to a voluntary agreement, known as a Prisoner 
Compact, and can be linked to the prison’s Incentive and Earned Privileges scheme. The 
evidence from Australia is that the establishment of drug free wings mak s a si nificant 
difference to reducing the use of drugs in prison (Incorvaia & Kirby, 1997). 
 
There is a suggestion from the US that restrictive prison r gimes with very formal 
prisoner-staff relations have less control over drug trafficking in prison than less 
restrictive regimes with more informal prisoner -staff r lations (Stevens, 1997). If this is 
so, it probably reflects the fact that there are many features of prison life that make a 
difference to the welfare of prisoners, and that well run prisons get generally better 
results than less well run prisons. For this reason, one of the objectives of the Prison 
Service (1998) strategy Tackling Drugs in Prison is the development of constructive 
regimes for all prisoners.   
 
Summary There is an urgent need to conduct independent, systematic and careful 
evaluations of drug services in prison. Like all prison-based research, such evaluation 
will have its difficulties, not least because variations in prison regimes complicate the 
assessment of prison-based treatment. It is difficult to isolate the success of a therapeutic 
unit from the effect of the prison regime, and the experimental design will need to take 
account of these special circumstances.  The success of a therapeutic unit is also 
contingent on the quality of aftercare, which is largely outside of the control of the prison 




The Prison Service is committed to introducing effective services for those prisoners who 
have problems with illicit drug use.  Although formal treatment appears to have a 
relatively minor role in helping people with drug problems, this strategy is ration l, in 
economic terms, because the benefits from reductions in offending behaviour and 
improvements in health status will outweigh the costs of treatment to the Prison Service.  
Intervention has the potential of improving prison security, as well as the health and 
social functioning of prisoners, and it can enhance the achievement of key Prison Service 
aims and objectives, such as the rehabilitation of offenders.   
 
Despite the commitment to evidence-based practice, there is a dearth of independent, 
systematic and careful valuations of drug services in UK prisons.  Many of the treatment 
programmes provided under contract by non-statutory drugs agencies are not supported 
by strong evidence of effectiveness.  The evidence is strongest for interventions based on 
behavioural principles, particularly if this is understood to include Motivational 
Interviewing.  There is also support for the introduction of methadone maintenance 
programmes within prison, provided these are integrated with psychological treatments 
and linked to ongoing care in the community, so that prisoners are referred to methadone 
maintenance programmes on release.   
 
The greatest threat to the success of prison-based treatment comes from the failure of 
throughcare and aftercare arrangements, which are partly beyond the control of the prison 
authorities. Consideration should be given to ways of integrating care in prison and on 
release, possibly using the American example of a multistage struc ure of day release and 
halfway houses. There is an urgent need for prisons in England and Wales to become 
involved in outcome evaluation, however, so that any such initiatives can be properly 






9. Acknowledgements  
 
Geoff Cooke, Area Drug Strategy Co-ordinator for the Prison Service, the East and West 
Kent Health Authorities and the West Sussex Drug Action Team, jointly commissioned 
this review. This paper was prepared as part of a project evaluating the outcome 
effectiveness of drug treatment services within Kent, East Surrey and Sussex prisons. 
Thanks to Emma Wincup of the University of Kent and John Weekes of th  Correctional 




American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental 
Disorders (4th Ed). Washington DC: APA.  
Annis, H. M. (1986a). Is inpatient rehabilitation of the alcoholic cost effective? Con 
position. In B. Stimmel (Ed.), Controversies in Alcoholism and Substance Abuse. New 
York: Haworth. 
Annis, H. M. (1986b). A Relapse Prevention Model for Treatment of Alcoholics. In W. 
R. Miller & N. Heather (Eds.), Treating Addictive Behaviours: Processes of Change. 
London: Plenum Press. 
Annis, H. M. (1987). Effective Treatment for Drugand Alcohol Problems:  What do we 
Know? Toronto, Canada: Addiction Research Foundation. 
Babor, T. (1995). The social and public health implications of individually directed 
interventions. In H. Holder & G. Edwards (Eds.), Alcohol and Public Policy: Evidence 
and Issues. Oxford: Oxford University Press. 
Baldwin, S. (Ed.). (1990). Alcohol Education and Offenders. London: Batsford. 
Baldwin, S., & Heather, N. (1987). Alcohol Education Courses for offenders:  A survey 
of British agencies. Alcohol and Alcoholism, 22(1), 79-82. 
Barnett, P. G. (1999). The cost-effectiveness of methadone maintenance as a health care 
intervention. Addiction, 94( ), 479-488. 
Barnett, P. G., Rodgers, J. H., & Bloch, D. A. (2001). A meta-analysis comparing 
buprenorphine to methadone for tr atment of opiate dependence. Addiction, 96(5), 683-
690. 
Bearn, J., Gossop, M., & Strang, J. (1996). Randomized double-blin  comparison of 
lofexidine and methadone in the in-patie t treatment of opiate withdrawal. D ug and 
Alcohol Dependence, 43(1/2), 87-91. 
Berlinger, A. K. (1987). Group counselling with alcohol offenders: an analysis and 
typology of DWI probationers. Social Work With Groups, 10, 17-32. 
Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief interventions for alcohol 
problems: a review. Addiction, 88(3), 315-336. 
Bischof, G., Rumpf, H.-J., Hapke, C., Meyer, C., & John, U. (2001). Factors influencing 
remission from alcohol dependence without formal help in a representative population 
sample. Addiction, 96(9), 1327-1336. 
Breslin, F. C., Sobell, S. L., Sobell, L. C., & Sobell, M. B. (1997). Alcohol treatment 
outcome methodology: State of the art 1989-1993. Addictive Behaviors, 22(2), 145-155. 
 41 
Brooke, D., Taylor, C., Gunn, J., & Maden, A. (1998). Substance misusers remanded to 
prison: A treatment opportunity? Addiction, 93(12), 1851- 856. 
Burrows, J., Clarke, E., Davison, T., Tarling, R., & Webb, S. (2000). Research into the 
Nature and Effectiveness of Drugs Throughcare RDS Occasional Paper 68. London: 
Home Office Research, Development and Statistics Directorate. 
Caplehorn, J., Dalton, M., Haldar, F., Petrenas, A. M., & Nisbet, J. G. (1996). Methadone 
maintenance and addicts' risk of fatal heroin overdose. Substanc  Use & Misuse, 31(2), 
177-196. 
Carroll, K. M. (1996). Relapse prevention as a psychosocial treatment: A review of 
controlled  clinical trials. Experimental and Clinical Psychopharmacology, 4(1), 46-54. 
Carter, B. L., & Tiffany, S. T. (1999). Meta-analysis of cue-r activity in addiction 
research. Addiction, 94(3), 327-340. 
Cartwright, W. S. (2000). Cost-benefit analysis of drug treatment services: Review of the 
literature. The Journal of Mental Health Policy and Economics, 3(11), 11-26. 
Chick, J., Anton, R., Checinski, K., Croop, R., Drummond, D. C., & Farmer, R. (2000). 
Multicentre, randomized, double- lind, placebo-c ntrolled trial of naltrexone in the 
treatment of alcohol dependence or abuse. Alcohol and Alcoholism, 35(6), 587-593. 
Coid, J., Carvell, A., Kittler, Z., Healey, A., & Henderson, J. (2000). The Impact of 
Methadone Treatment on Drug Misuse and Crime Home Office Research, Development 
and Statistics Directorate Research Findings No 120. London: Home Office Research, 
Development and Statistics Directorate. 
Condelli, W. S., & Hubbard, R. L. (1994). Relationship between time spent in tr atment 
and client outcomes from therapeutic communities. Jo rnal of Substance Abuse 
Treatment, 11( ), 25-33. 
Conklin, C. A., & Tiffany, S. T. (2002). Applying extinction research and theory to cue-
exposure addiction treatments. Addiction, 97(2), 155-167. 
Copello, A., Godfrey, C., Heather, N., Hodgson, R., Orford, J., & Raistrick, D. (2001). 
United Kingdom Alcohol Treatment Trial (UKATT): Hypotheses, design and methods. 
Alcohol and Alcoholism, 36(1), 11-21. 
Costello, R. M. (1980). Alcoholism Treatment Effectiveness:  Slicing the Outcome 
Variance Pie. In G. Edwards & M. Grant (Eds.), Alcoholism Treatment in Transition. 
London: Croom Helm. 
Crundall, I., & Deacon, K. (1997). A prison-ba ed alcohol use education program: 
Evaluation of a pilot study. Substance Use & Misuse, 32(6), 767- 77. 
 42 
Darke, S., Kaye, S., & Finlay, J. R. (1998). Drug use and injection risk-taking among 
prison methadone maintenance patients. Addiction, 93(8), 1169-1175. 
De Leon, G., Hawke, J., Jainchill, N., & Melnick, G. (2000). Therapeutic communities: 
Enhancing retention in treatment using "Senior Professor" staff. Journal of Substance 
Abuse Treatment, 19(4), 375-382. 
De Leon, G., Melnick, G., Thomas, G., Kressel, D., & Wexler, H. K. (2000). Motivation 
for treatment in a prison-based therapeutic community. American Journal of Drug and 
Alcohol Abuse, 26(1), 33-46. 
Dolan, K., Hall, W., & Wodak, A. (1998). Provision of methadone within prison settings. 
In J. Ward & R. Mattick & W. Hall (Eds.), Methadone Maintenance Treatment and other 
Opiate Replacement Therapies. Amsterdam: Harwood Academic Publishing. 
Dolan, K., & Wodak, A. (1996). An international review of methadone provision in 
prisons. Addiction Research, 4(1), 85-87. 
Dolan, K., Wodak, A. D., & Hall, W. D. (1998). Methadone maintenance treatment 
reduces heroin injection in New South Wales prisons. Drug a d Alcohol Review, 17(2), 
153-158. 
Drugs Strategy Directorate (2002). Updated Drug Strategy. London: Home Office. 
Dugan, J. R., & Everett, R. S. (1998). An experimental test of chemical dependency 
therapy for jail inmates. International Journal of Offender Therapy and Comparative 
Criminology, 42(4), 360-368. 
Edens, J. F., Peters, R. H., & Hills, H. A. (1997). Treating prison inmates with co-
occurring disorders: An integrative review of existing programs. Behavioral Sciences and 
the Law, 15(4), 439-457. 
Edgar, K., & O'Donnell, I. (1998). Mandatory Drug Testing in Prisons: the Relationship 
between MDT and the Level and Nature of Drug UseResearch and Statistics Directorate 
Report. London: Home Office. 
Egg, R., Pearson, F. S., Cleland, C. M., & Lipton, D. S. (2000). Evaluations of 
correctional treatment programs in Germany: A review and meta-analysis. Substance Use 
& Misuse, 12(14), 1967-2009. 
Eisenberg, M., & Fabelo, T. (1996). Evaluation of the Texas correctional substance abuse 
treatment initiative: The impact of policy research. Crime & Delinquency, 42(2), 296-
308. 
Emrick, C. D. (1975). A review of psychologically oriented treatment of alcoholism II.  
The relative effectiveness of different treatment approaches and the effectiveness of 
treatment versus no treatment. Journal of Studies on Alcohol, 36(1), 88-108. 
 43 
Farre, M., Mas, A., Torrens, M., Moreno, V., & Cami, J. (2002). Retention rate and illicit 
opioid use during methadone maintenance  i terventions: A meta-analysis. Drug and 
Alcohol Dependence, 65(3), 283-290. 
Field, G. (1992). Oregon prison drug treatment programs. In C. Leukefeld & F. Tims 
(Eds.), Drug Abuse Treatment in Prisons and Jails: Nida Research Monograph. 
Freudenberg, N. (2001). Jails, prisons, and the health of urban populations: A review of 
the impact of the correctional system on community health. Journal of Urban Health, 
78(2), 214-235. 
Gaes, G.G., Flanagan, T.J., Motiuk, L.L., & Stewart, L. (1999). Adult correctional 
treatment. In M. Tonry and J. Petersilia (Eds.) Prisons, 
Crime and Justice: A Review of Research, Volume 26. Chicago: University of Chicago 
Press. 
Georgiou, A. J., Spencer, C. P., Davies, G. K., & Stamp, J. (1998). Electrical stimulation 
therapy in the trea ment of cigarette smoking. Journal of Substance Abuse, 10(3), 265-
274. 
Glanz, M., Klawansky, S., McAullife, W., & Chalmers, T. (1997). Methadone vs. L-
alpha-acetylmethadol (LAAM) in the treatment of opiate addiction: A meta-analysis of 
the randomized, contr lled trials. American Journal on Addictions, 6(4), 339-349. 
Glatt, M. M. (1982). Alcoholism:  A Social Disease. London: Hodder and Stroughton. 
Godfrey, C. (1992). The Cost-Effectiveness of Alcohol Services: Lessons for 
Contracting? York: Centre for Health Economics, University of York. 
Gossop, M., Marsden, J., & Stewart, D. (1998). National Treatment Outcome Research 
Study at One Year. London: Department of Health. 
Grabowski, J., Rhoades, H., Silverman, P., Schmitz, J. M., Stotts, A., & Creson, D. 
(2000). Risperidone for the treatment of cocaine dependence: Randomized, double-blind 
trial. Journal of Clinical Psychopharmacology, 20(3), 305-310. 
Gravett, S. (2000). Drugs in Prison: A Practitioner's Guide. London: Continuum. 
Griffith, J. D., Rowan, S. G., Roark, R. R., & Simpson, D. D. (2000). Contingency 
management in outpatient methadone treatment: A meta-a alysis. Drug and Alcohol 
Dependence, 1(2), 55-66. 
Guyon, L., Brochu, S., Parent, I., & Desjardins, L. (1999). At-risk behaviors with regard 
to HIV and addiction among women in prison. Women & Health, 29(3), 49-66. 
Hammersley, R., Forsyth, A., Morrison, V., & Davies, J. B. (1989). The relationship 
between crime and opioid use. British Journal of Addiction, 84(9), 1029-1043. 
 44 
Harrison, L. (Ed.). (1996). Alcohol Problems in the Community. London: Routledge. 
Harwood, H. J., Hubbard, R. L., Collins, J. J., & Rachel, J. V. (1988). The costs of crime 
and the benefits of drug abuse treatment: A cost-benefit analysis using TOPS data. In C. 
Leukefeld & F. Tims (Eds.), Compulsory Treatment of Drug Abuse: Research and 
Clinical Practice. Nida Research Monograph. Rockville, Md: NIDA. 
Hiller, M. L., Knight, K., & Simpson, D. D. (1999). Prison-based substance abuse 
treatment residential aftercare and recidivism. Ad ction, 94(6), 833-842. 
HM Chief Inspector of Prisons. (1999). Suicide is Everyone's Concern: A thematic review 
by HM Chief Inspector of Prisons for England and Wales. London: Home Office. 
Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991). The cost 
effectiveness of treatment of alcoholism: A first approximation. Journal of Studies on 
Alcohol, 52(6), 517-540. 
Home Office. (1988). Punishment, Custody and the Community. London: HMSO. 
Home Office. (2001). Prison Statistics England and Wales 2000 Cm 5250. London: 
HMSO. 
Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. (1997). 
Overview of 1-year outcomes in the Drug Abuse Treatment Outcome Study (DATOS). 
Psychol Addict Behav: 11 (4), p.261-278. 
Hunt, G., Mellor, J., & Turner, J. (1992). From alcoholism to problem drinking: Alcohol 
treatment in England and Wales, 1945-1990. In H. Klingemann & J. Takala & G. Hunt 
(Eds.), Cure, Care or Control:  Alcoholism Treatment in Sixteen Countries. Albany, Ny: 
State University of New York Press. 
Hutchinson, S. J., Goldberg, D. J., Gore, S. M., Cameron, S., McGregor, J., McMenamin, 
J., & McGavigan, J. (1998). Hepatitis B outbreak at Glenochil prison during January to 
June 1993. Epidemiology and Infection, 121(1), 185-191. 
Inciardi, J. A., Lockwood, D.,& Martin, S. S. (1994). Therapeutic communities in 
corrections and work release: Some clinical and policy considerations. In F. M. Tims & 
G. De Leon & N. Jainchill (Eds.), Therapeutic Community: Advances in Research and 
Application. Nida Research Monograph. Rockville, Md: NIDA. 
Inciardi, J. A., Martin, S. S., Butzin, C. A., Hooper, R. M., & Harrison, L. D. (1997). An 
effective model of prison-based treatment for drug-involved offenders. Journal of Drug 
Issues, 27(2), 261-278. 
Incorvaia, D., & Kirby, N. (1997). A formative evaluation of a drug-free unit in a 
correctional services setting. International Journal of Offender Therapy and Comparative 
Criminology, 41(3), 231-249. 
 45 
Irvin, J. E., Bowers, C. A., Dunn, M. E., & Wang, M. C. (1999). Efficacy of relapse 
prevention: A meta-analytic review. Journal of Consulting and Clinical Psychology, 
67(4), 563-570. 
Jeanmonod, R., Harding, T., & Staub, C. (1991). Treatment of opiate withdrawal on entry 
to prison. British Journal of Addiction, 86(4), 457-463. 
Kampman, K., Volpicelli, J. R., Alterman, A. I., Cornish, J., Weinrieb, R., & Epperson, 
L. (1996). Amantadine in the early treatment of cocaine dependence: A double blind,    
placebo-controlled trial. Drug and Alcohol Dependence, 41(1) 25-33. 
Keene, J. (1997). Drug use among prisoners before, during and after custody. Addic ion 
Research, 4( ), 343- 53. 
Kownacki, R. J., & Shadish, W. R. (1999). Does Alcoholics Anonymous work? The 
results from a meta-an lysis of controlled experiments. Substance Use & Misuse, 34(13), 
1897-1916. 
Lord President of the Council. (1995). Tackling Drugs Together: A Strategy for England 
1995-98 Cm 2846. London: HMSO. 
Lord President of the Council. (1998). Tackling Drugs to Build a Better Britain: the 
Government's Ten-Year Strategy for Tackling Drugs Misuse Cm. 3945. London: 
Stationery Office. 
Lurigio, A. J., & Swartz, J. (1994). Life at the interface: Issues in the implementation and 
evaluation of a multiphased, multiagency jail-based treatment program. Evaluation and 
Program Planning, 17(2), 205-216. 
MacMillan, J., & Baldwin, S. (1993). A pilot study of an alcohol education course for 
young women offenders: What's good for the goose. Alcohol and Alcoholism, 28(4), 499-
504. 
Maden, A., Swinton, M., & Gunn, J. (1992). A survey of pre-arrest drug use in sentenced 
prisoners. British Journal of Addiction, 87(1), 27-33. 
Magura, S., Rosenblum, A., & Joseph, H. (1992). Evaluation of in-jail methadone 
maintenance: Preliminary results. In C. G. Leukefeld & F. M. Tims (Eds.), Drug Abuse
Treatment in Prisons ad Jails. Rockville, MD: National Institute on Drug Abuse. 
Malliori, M., Sypsa, V., Psichogiou, M., Touloumi, G., Skoutelis, A., & Tassopoulos, N. 
(1998). A survey of bloodborne viruses and associated risk behaviours in Greek prisons. 
Addiction, 93(2), 243-251. 
Marlatt, G. A., & Gordon, J. R. (Eds.). (1985). Relapse Prevention:    Maintenance 
Strategies in the Treatment of Addictive Behaviours. Lond n: The Guilford Press. 
 46 
Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing 
illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93(4), 
515-532. 
Marshall, R. (1996). Social influences on treatment outcomes. In L. Harrison (Ed.), 
Alcohol Problems in the Community. London: Routledge. 
Martin, C., & Player, E. (2000). Drug Treatment in Prison: An evaluation of the RAPt 
Treatment Programme. Winchester: Waterside Press. 
Martin, S. S., Butzin, C. A., & Inciardi, J. A. (1995). Assessment of a multistage 
therapeutic community for drug-involved offenders. Journal of Psychoactive Drugs, 
27(1), 109-116. 
Martin, V., Cayla, J. A., Bolea, A., & Castilla, J. (2000). Mycobacterium tuberculosis and 
human immunodeficiency virus co-infe tion in intravenous drug users on admission to 
prison. International Journal of Tuberculosis and Lung Disease, 4(1), 41-46. 
McCrady, B. (1991). Promising but Underutilized Treatment Approaches. lcohol Health 
and Research World, 15(3), 215-218. 
McMurran, M., & Baldwin, S. (1989). Services for prisoners with alcohol-related 
problems: A survey of UK prisoners. British Journal of Addiction, 84(9), 1053-1058. 
Miller, W. R. (2000). Rediscovering fire: Small interventions, large effects. Psychology 
of Addictive Behaviors, 14(1), 6-18. 
Miller, W. R., Benefield, R. G., & Tonigan, J. S. (1993). Enhancing motivation for 
change in problem drinking: A controlled comparison of two therapist styles. Journal of 
Consulting and Clinical Psychology, 61(3) 455-461. 
Miller, W. R., Brown, J. M., & Simpson, T. L. (1995). What Works?  A methodological 
analysis of the alcohol treatment outcome literature. In R. K. Hester & W. R. Miller 
(Eds.), Handbook of Alcoholism Treatment Approaches:  Effective Alternatives (2nd ed.). 
Needham Heights Ms: Allyn & Bacon. 
Miller, W. R., & Brown, S. A. (1997). Why psychologists should treat a cohol and drug 
problems. American Psychologist, 52(12), 1269-1279. 
Miller, W. R., & Hester, R. K. (1986). The effectiveness of alcoholism treatment: What 
research reveals. In W. R. Miller & N. Heather (Eds.), Treating Addictive Behaviors: 
Processes of Change. New York: Plenum Press. 
Miller, W. R., & Rollnick, S. (1991). Motivational Interviewing: Preparing People to 
Change Addictive Behavior. New York: The Guilford Press. 
Miller, W. R., Walters, S. T., & Bennett, M. E. (2001). How effective is alcoholism
treatment in the United States? Journal of Studies on Alcohol, 62(2), 11-220. 
 47 
Miller, W. R., & Wilbourne, P. L. (2002). Mesa Grande: a methodological analysis of 
clinical trials of treatments for alcohol use disorders. Addiction, 97(3), 265-277. 
Montoya, I. D., Levin, F. R., Fudala, P. J., & Gorelick, D. A. (1995). Double-blind 
comparison of carbamazepine and placebo for treatment of cocaine    dependence. Drug 
and Alcohol Dependence, 38(3), 213-219. 
Moyer, A., Finney, J. W., & Swearingen, C. A. (2002). Methodological characteristics 
and quality of alcohol treatment outcome studies, 1970-98: an expanded evaluation. 
Addiction, 97(3), 253-263. 
Moyer, A., Finney, J. W., Swearingen, C. A., & Vergun, P. (2002). Brief interventions 
for alcohol problems, 1970-98: a meta-analytic review of controlled investigations in 
treatment-seeking and non-treatment-seeking populations. Addiction, 97(3), 279-292. 
Nealon, W. M., Ferrari, J. R., & Jason, L. A. (1995). Twelve-step program use among 
Oxford House residents: Spirituality or social support in sobriety? Journal of Substance 
Abuse, 7(3), 311-318. 
NIDA. (1996). Individual Differences in the Biobehavioral Etiology of Drug Abuse. 
Rockville, Md: National Institute on Drug Abuse. 
Nielsen, A. L., Scarpitti, F. R., & Inciardi, J. A. (1996). Integrating the therapeutic 
community and work release for drug-involved offenders: The CREST Program. Journal 
of Substance Abuse Treatment, 13(4), 349-358. 
Orford, J., & Edwards, G. (1977). Alcoholism:  a comparison of treatment and advice 
with a study of the influence of marriage. Oxford: Oxford University Press. 
Panepinto, W., Garret, J., Wilford, W., & Priebe, J. (1982). A short-term gr up treatment 
for problem-drinking drivers. Social Work Group, 5((1)), 33-40. 
Parliamentary All-Party Drugs Misuse Group. (1998). Prisons and Drugs Misuse. 
London: HMSO. 
Prison Service. (1998). Tackling Drugs in Prison: The New Prison Service Drug 
Strategy. London: Directorate of Regimes, Prison Service. 
Prison Service Agency. (2001). Prison Service Drug Strategy 
http://www.hmprisonservice.gov.uk. Accessed on 5/12/2001. 
Prochaska, J., & DiClemente, C. (1986). Toward a Comprehensive Model of Change. In 
W. Miller & N. Heather (Eds.), Treating Addictive Behaviours. New York, NY: Plenum 
Press. 
Project MATCH Research Group. (1997). Matching Alcoholism Treatments to Client 
Heterogeneity: Project MATCH post-trea ment drinking outcomes. Journal of Studies on 
Alcohol, 58(1), 7-29. 
 48 
Project MATCH Research Group, Allen, J., Anton, R. F., Babor, T. F., Carbonari, J., & 
Carroll, K. M. (1997). Project MATCH secondary a priori hypotheses. Addiction, 92(12), 
1671-1698. 
Raistrick, D., Hodgson, R., & Ritson, B. (Eds.). (1999). Tackling Alcohol Together. 
London: Free Association Books. 
Riet, G. T., Kleijnen, J., & Knipschild, P. (1990). A meta-analysis of studies into the 
effect of acupuncture on addiction  (review article). British Journal of General Practice, 
40(338), 379-382. 
Shewan, D., Hammersley, R., Oliver, J., & MacPherson, S. (2000). Fatal drug overdose 
after liberation from prison: A retrospective study of female ex-prisoners from 
Strathclyde region (Scotland). Ad iction Research, 8(3), 267-278. 
Smeeth, L., & Fowler, G. (1990). Research issues in assessing addiction treatment 
efficacy: How cost-effective are Alcoholics Anonymous and private treatment centers. 
Drug and Alcohol Dependence, 25(2) 179-182. 
Smith, J. E., Meyers, R. J., & Miller, W. R. (2001). The community reinforcement 
approach to the treatment of substance u e disorders. American Journal on Addictions, 
10(Supplement), 51- 9. 
Sobell, L. C., Cunningham, J. A., & Sobell, M. B. (1996). Recovery from alcohol 
problems with and without treatment: prevalence in two population surveys. American 
Journal of Public Health, 7, 966-972. 
Social Services Committee. (1986). Third Report from the House of Commons Social 
Services Committee - the Prison Medical Service. London: HMSO. 
Stevens, D. J. (1997). Prison Regime and Drugs. Howard Journal of Criminal Justice, 36, 
14-27(14). 
Strauss, S. M., & Falkin, G. P. (2000). The relationship between the quality of drug user 
treatment and program completion: Understanding the perceptions of women in a prison-
based program. Substance Use & Misuse, 12(14), 2127-2159. 
Swann, R., & James, P. (1998). The Effect of the Prison Environment upon Inmate Drug 
Taking Behaviour. Howard Journal of Criminal Justice, 37, 252-265(214). 
Taylor, R. (2000). A Seven-Year Reconviction Study of HMP Grendon Therapeutic 
Community Home Office Research, Development and Statistics Directorate, Research 
Findings No 115. London: Home Office Research, Development and Statistics 
Directorate. 
Vaillant, G. (1966). A twelve-year follow-up of New York Narcotic Addicts: IV, Some 
characteristics and determinants of abstinence. American Journal of  Psychiatry, 123, 
573-584. 
 49 
Vaillant, G. (1995). The Natural History of Alcoholism Revisited. London: Harvard 
University Press. 
Vennard, J., Hedderman, C., & Sugg, D. (1997). Changing Offenders' Attitudes and 
Behaviour: What Works? Home Office Research Study No 171. London: Home Office. 
West, S. L., O'Neal, K. K., & Graham, C. W. (2000). A meta-analysis comparing the 
effectiveness of buprenorphine and methadone. Journal of Substance Abuse, 12(4), 405-
414. 
Wexler, H. K. (1995). The success of therapeutic communities for substance abusers in 
American prisons. Journal of Psychoactive Drugs, 27(1), 57-66. 
Wexler, H. K., De, L. G., Thomas, G., Kressel, D., & Peters, J. (1999). The Amity prison 
TC evaluation: Reincarceration outcomes. Cri inal Justice and Behavior, 26(2), 147-
167. 
Wilson, G. T. (1987). Chemical aversion conditioning as a treatment for alcoholism: A 
re-analysis. Behaviour Research and Therapy, 25(6), 503-516. 
 
 
